Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 17

1.

Induction of Lysosome-associated Protein Transmembrane 4 Beta via Sulfatase 2 Enhances Autophagic Flux in Liver Cancer Cells.

Ha Y, Fang Y, Romecin Duran PA, Tolosa EJ, Moser CD, Fernandez-Zapico ME, Roberts LR.

Hepatol Commun. 2019 Sep 25;3(11):1520-1543. doi: 10.1002/hep4.1429. eCollection 2019 Nov.

2.

Circulating tumor cells are associated with poor outcomes in early-stage hepatocellular carcinoma: a prospective study.

Ha Y, Kim TH, Shim JE, Yoon S, Jun MJ, Cho YH, Lee HC.

Hepatol Int. 2019 Nov;13(6):726-735. doi: 10.1007/s12072-019-09994-9. Epub 2019 Nov 5.

PMID:
31691073
3.
4.

Validation of the Liver Disease Quality of Life Instrument 1.0 in Patients with Chronic Hepatitis B: A Prospective Study.

Ha Y, Hwang S, Chon YE, Kim MN, Lee JH, Hwang SG.

J Clin Med. 2019 May 10;8(5). pii: E656. doi: 10.3390/jcm8050656.

5.

Development of a New Nomogram Including Neutrophil-to-Lymphocyte Ratio to Predict Survival in Patients with Hepatocellular Carcinoma Undergoing Transarterial Chemoembolization.

Chon YE, Park H, Hyun HK, Ha Y, Kim MN, Kim BK, Lee JH, Kim SU, Kim DY, Ahn SH, Hwang SG, Han KH, Rim KS, Park JY.

Cancers (Basel). 2019 Apr 10;11(4). pii: E509. doi: 10.3390/cancers11040509.

6.

Association between hepatic steatosis and the development of hepatocellular carcinoma in patients with chronic hepatitis B.

Lee YB, Ha Y, Chon YE, Kim MN, Lee JH, Park H, Kim KI, Kim SH, Rim KS, Hwang SG.

Clin Mol Hepatol. 2019 Mar;25(1):52-64. doi: 10.3350/cmh.2018.0040. Epub 2018 Oct 23.

7.

Sarcopenia Predicts Prognosis in Patients with Newly Diagnosed Hepatocellular Carcinoma, Independent of Tumor Stage and Liver Function.

Ha Y, Kim D, Han S, Chon YE, Lee YB, Kim MN, Lee JH, Park H, Rim KS, Hwang SG.

Cancer Res Treat. 2018 Jul;50(3):843-851. doi: 10.4143/crt.2017.232. Epub 2017 Sep 4.

8.

The Association between Vitamin D Insufficiency and Nonalcoholic Fatty Liver Disease: A Population-Based Study.

Ha Y, Hwang SG, Rim KS.

Nutrients. 2017 Jul 27;9(8). pii: E806. doi: 10.3390/nu9080806.

9.

Role of Computed Tomography Volumetry in Estimating Liver Weights in Surgical Patients with Hepatic Steatosis.

Ha Y, Shim JH, Song GW, Kim SO, Ha TY, Jung DH, Kim KM, Lim YS, Lee HC, Lee SG.

Exp Clin Transplant. 2017 Apr;15(2):196-202. doi: 10.6002/ect.2016.0065.

10.

Role of transarterial chemoembolization in relation with sorafenib for patients with advanced hepatocellular carcinoma.

Ha Y, Lee D, Shim JH, Lim YS, Lee HC, Chung YH, Lee YS, Park SR, Ryu MH, Ryoo BY, Kang YK, Kim KM.

Oncotarget. 2016 Nov 8;7(45):74303-74313. doi: 10.18632/oncotarget.11030.

11.

Validation and reappraisal of the assessment for retreatment with transarterial chemoembolization score for unresectable non-metastatic hepatocellular carcinoma in a hepatitis b virus-endemic region.

Ha Y, Lee JB, Shim JH, Kim KM, Lim YS, Yoon HK, Shin YM, Lee HC.

Eur Radiol. 2016 Oct;26(10):3510-8. doi: 10.1007/s00330-015-4185-2. Epub 2016 Jan 8.

PMID:
26747261
12.

Nomograms for Predicting Outcomes after Chemoembolization in Patients with Nonmetastatic Hepatocellular Carcinoma.

Ha Y, Han S, Shim JH, Ko GY, Yoon HK, Sung KB, Lee D, Kim KM, Lim YS, Chung YH, Lee YS, Lee HC.

J Vasc Interv Radiol. 2015 Aug;26(8):1093-1101.e1. doi: 10.1016/j.jvir.2015.04.010. Epub 2015 Jun 13.

PMID:
26077020
13.

Intimate association of visceral obesity with non-alcoholic fatty liver disease in healthy Asians: A case-control study.

Ha Y, Seo N, Shim JH, Kim SY, Park JA, Han S, Kim KW, Yu E, Kim KM, Lim YS, Lee HC, Chung YH, Lee YS.

J Gastroenterol Hepatol. 2015 Nov;30(11):1666-72. doi: 10.1111/jgh.12996.

PMID:
25974139
14.

Comparison of clinical outcomes associated with pull-type and introducer-type percutaneous endoscopic gastrostomies.

Lee SW, Lee JH, Cho H, Ha Y, Lim H, Ahn JY, Choi KS, Kim DH, Choi KD, Song HJ, Lee GH, Jung HY, Kim JH.

Clin Endosc. 2014 Nov;47(6):530-7. doi: 10.5946/ce.2014.47.6.530. Epub 2014 Nov 30.

15.

Incidence of hepatocellular carcinoma after HBsAg seroclearance in chronic hepatitis B patients: a need for surveillance.

Kim GA, Lee HC, Kim MJ, Ha Y, Park EJ, An J, Lee D, Shim JH, Kim KM, Lim YS.

J Hepatol. 2015 May;62(5):1092-9. doi: 10.1016/j.jhep.2014.11.031. Epub 2014 Nov 28.

PMID:
25445399
16.

[Clinical usefulness of bile cytology obtained from biliary drainage tube for diagnosing cholangiocarcinoma].

Kim JY, Choi JH, Kim JH, Kim CL, Bae SH, Choi YK, Ha Y, Song MJ, Choi JH, Hong SM, Kim MH.

Korean J Gastroenterol. 2014 Feb;63(2):107-13. Korean.

17.

Clinical appraisal of the recently proposed Barcelona Clinic Liver Cancer stage B subclassification by survival analysis.

Ha Y, Shim JH, Kim SO, Kim KM, Lim YS, Lee HC.

J Gastroenterol Hepatol. 2014 Apr;29(4):787-93. doi: 10.1111/jgh.12452.

PMID:
24224567

Supplemental Content

Loading ...
Support Center